Evidence map›Paper›PMID 41411777›Full record

ArticleComputer methods and programs in biomedicine2026

A subject-based association network defines new pediatric sleep apnea phenotypes with different odds of recovery after treatment.

Gonzalo C Gutiérrez-Tobal, Javier Gomez-Pilar, Daniela Ferreira-Santos, Pedro Pereira-Rodrigues, Daniel Álvarez, Félix Del Campo, David Gozal, Roberto Hornero

Abstract read
In one paragraph

Article in Computer methods and programs in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gonzalo C Gutiérrez-TobalBiomedical Engineering Group, University of Valladolid, Valladolid, Spain; CIBER-BBN, Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina, Valladolid, Spain. Electronic address: gonzalocesar.gutierrez@uva.es.
Javier Gomez-PilarBiomedical Engineering Group, University of Valladolid, Valladolid, Spain; CIBER-BBN, Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina, Valladolid, Spain.
Daniela Ferreira-SantosDepartment of Technical Physics, University of Eastern Finland, Kuopio, Finland; CINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.
Pedro Pereira-RodriguesCINTESIS@RISE, MEDCIDS, Faculty of Medicine of the University of Porto, Porto, Portugal.
Daniel ÁlvarezBiomedical Engineering Group, University of Valladolid, Valladolid, Spain; CIBER-BBN, Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina, Valladolid, Spain.
Félix Del CampoBiomedical Engineering Group, University of Valladolid, Valladolid, Spain; CIBER-BBN, Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina, Valladolid, Spain; Sleep-Ventilation Unit, Pneumology Department, Río Hortega University Hospital, Valladolid, Spain.
David GozalOffice of The Dean, and Department of Pediatrics Joan C. Edwards School of Medicine, Marshall University, 1600 Medical Center Dr, Huntington, WV, 25701, USA.
Roberto HorneroBiomedical Engineering Group, University of Valladolid, Valladolid, Spain; CIBER-BBN, Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina, Valladolid, Spain.

Funding

APP-mediated signaling, sleep perturbations, and Alzheimer's disease mouse modelsRF1AG061824 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI GOZAL, DAVID, PARENT, ANGELE · 2019 to 2019
$3.5M
Coronary artery dysfunction in OSA: Role of mineralocorticoid receptorsR01HL166617 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI Mohammad Badran · 2023 to 2026
$2.5M
NHLBI NIH HHS R01 HL166617NIA NIH HHS RF1 AG061824
6 · The paper itself

Abstract

BACKGROUND AND

objectivesTimely treatment of pediatric obstructive sleep apnea (OSA) can prevent or reverse neurocognitive and cardiovascular morbidities. However, whether distinct phenotypes exist and account for divergent treatment effectiveness remains unknown. In this study, our goal is threefold: i) to define new data-driven pediatric OSA phenotypes, ii) to evaluate possible treatment effectiveness differences among them, and iii) to assess phenotypic information in predicting OSA resolution.

methodsWe involved 22 sociodemographic, anthropometric, and clinical data from 464 children (5-10 years old) from the Childhood Adenotonsillectomy Trial (CHAT) database. Baseline information was used to automatically define pediatric OSA phenotypes using a new unsupervised subject-based association network. Follow-up data (7 months later) were used to evaluate the effects of the therapeutic intervention in terms of changes in the obstructive apnea-hypopnea index (OAHI) and the resolution of OSA (OAHI < 1 event per hour). An explainable artificial intelligence (XAI) approach was also developed to assess phenotypic information as OSA resolution predictor at baseline.

resultsOur approach identified three OSA phenotypes (PH

conclusionsOur new subject-based association network successfully identified three clinically useful pediatric OSA phenotypes with different odds of therapeutic intervention effectiveness. Specifically, we found that children of any sex, >6 years old, overweight or obese, and with enlarged neck and waist circumference (PH

Indexed as

Sleep Apnea, ObstructiveSleep Apnea SyndromesAdenoidectomyArtificial IntelligenceChildChild, PreschoolFemaleHumansMalePhenotypeTonsillectomyTreatment OutcomeAssociation networkChildhood adenotonsillectomy trialExplainable artificial intelligenceObstructive sleep apneaPhenotypes

Identifiers

PMID41411777
PMCPMC13333997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.